Tirzepatide / Semaglutide / Ozempic Injectables
Dual GIP/GLP-1 receptor agonist injectables manufactured at commercial scale under FDA 506e designation. Available in multi-dose vials and auto-injector pen formats with full pharmacokinetic data packages.
Request data sheet / CoA506E-Registered GLP-1 Manufacturer